Restricted accessResearch articleFirst published online 2023-11
Negative Lymph Node Is an Independent Prognostic Factor for Stage III Gastric Cancer Patients After Curative Gastrectomy: A Surveillance,Epidemiology,and End Results-Based Study
Negative lymph node (NLN)’ s prognostic impact on stage III gastric cancer (GC) patients after curative gastrectomy has not been rigorously studied. We aimed to explore the relationship between NLNs count and outcomes of stage III GC patients.
Methods
We retrospectively investigated stage III gastric cancer cases between 2008 and 2018 from Surveillance, Epidemiology, and End Results (SEER) database. Variables were compared by chi2 test. Kaplan-Meier methods and COX proportional hazard models were used to ascertain independent prognostic factors. Survival differences among the subgroups were analyzed to assess the effects of NLN count on overall survival (OS) in stage III GC patients.
Results
2373 patients with curative gastrectomy for stage III GC were identified. Univariate analysis demonstrated that NLNs count >14 was associated better 5-year OS (43.7% VS 23.1%, P< .001) comparing with the NLNs count ≤ 14. Subgroup analysis showed that the NLNs count could predict survival in both node-negative and node-positive patients. Multivariate analysis revealed NLNs count is an independent prognostic factor.
Conclusions
The NLNs count is an independent prognostic factor for survival in stage III gastric cancer patients after curative gastrectomy and should be recommended for clinical applications.
ThriftAPEl-SeragHB. Burden of Gastric Cancer. Clinical gastroenterology and hepatology: the official clinical practice. Journal of the American Gastroenterological Association. 2020;18(3):534-542.
3.
WagnerADLordickFGrabschHI, et al.Multidisciplinary management of stage II-III gastric and gastro-oesophageal junction cancer. European Journal of Cancer (Oxford, England : 1990). 2020;124:67-76.
4.
CavatortaOScidaSMiragliaC, et al.Epidemiology of gastric cancer and risk factors. Acta Bio-Medica : Atenei Parmensis. 2018;89(8-s):82-87.
5.
DegiuliMDe ManzoniGDi LeoA, et al.Gastric cancer: Current status of lymph node dissection. World Journal of Gastroenterology. 2016;22(10):2875-2893.
6.
ZhangWHSongXHChenXZ, et al.Characteristics and survival outcomes related to the infra-pyloric lymph node status of gastric cancer patients. World Journal of Surgical Oncology. 2018;16(1):116.
7.
TaniguchiKOtaMYamadaT, et al.Staging of gastric cancer with the Clinical Stage Prediction score. World Journal of Surgical Oncology. 2019;17(1):47.
8.
IkomaNEstrellaJSBlumM, et al.Central Lymph Node Metastasis in Gastric Cancer Is Predictive of Survival After Preoperative Therapy. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract. 2018;22(8):1325-1333.
9.
ChenYZhangLTianJRenXHaoQ. Combining the negative lymph nodes count with the ratio of positive and removed lymph nodes can better predict the postoperative survival in cervical cancer patients. Cancer Cell International. 2013;13(1):6.
10.
JohnsonPMPorterGARicciardiRBaxterNN. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2006;24(22):3570-3575.
11.
LiQZhuoCCaiG, et al.Increased number of negative lymph nodes is associated with improved cancer specific survival in pathological IIIB and IIIC rectal cancer treated with preoperative radiotherapy. Oncotarget. 2014;5(23):12459-12471.
12.
DengJLiangHWangD, et al.Enhancement the prediction of postoperative survival in gastric cancer by combining the negative lymph node count with ratio between positive and examined lymph nodes. Annals of Surgical Oncology. 2010;17(4):1043-1051.
13.
KeBSongXNLiuN, et al.Prognostic value of the lymph node ratio in stage III gastric cancer patients undergoing radical resection. PloS One. 2014;9(5):e96455.
14.
KarlssonPColeBFPriceKN, et al.The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 2007;25(15):2019-2026.
15.
OgumaJOzawaSKazunoA, et al.Prognostic impact of lymphovascular invasion in lymph node-negative superficial esophageal squamous cell carcinoma. Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus. 2019;32(11):doz001.
16.
InHSolskyIPalisBLangdon-EmbryMAjaniJSanoT. Validation of the 8th Edition of the AJCC TNM Staging System for Gastric Cancer using the National Cancer Database. Annals of Surgical Oncology. 2017;24(12):3683-3691.
17.
DengJLiangHSunD, et al.Prognosis of gastric cancer patients with node-negative metastasis following curative resection: outcomes of the survival and recurrence. Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie. 2008;22(10):835-839.
18.
SanoTCoitDGKimHH, et al.Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project. Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2017;20(2):217-225.
19.
LeeEChaeYKimI, et al.Prognostic relevance of immunohistochemically detected lymph node micrometastasis in patients with gastric carcinoma. Cancer. 2002;94(11):2867-2873.
20.
MorgagniPSaragoniLScarpiE, et al.Lymph node micrometastases in early gastric cancer and their impact on prognosis. World journal of surgery. 2003;27(5):558-561.
21.
ZhangNDengJWangW, et al.Negative lymph node count as an independent prognostic factor in stage III patients after curative gastrectomy: A retrospective cohort study based on a multicenter database. Int J Surg. 2020;74:44-52.
22.
HuangCMLinJXZhengCH, et al.Effect of negative lymph node count on survival for gastric cancer after curative distal gastrectomy. European journal of surgical oncology : The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2011;37(6):481-487.
23.
WuSGPengFZhouJ, et al.Number of negative lymph nodes can predict survival after postmastectomy radiotherapy according to different breast cancer subtypes. Journal of Cancer. 2015;6(3):261-269.
24.
ZhangWZhangyuanGWangJ, et al.Effect of lymph nodes count in node-positive gastric cancer. Journal of Cancer. 2019;10(23):5646-5653.
25.
ZhangNBaiHDengJ, et al.Impact of examined lymph node count on staging and long-term survival of patients with node-negative stage III gastric cancer: a retrospective study using a Chinese multi-institutional registry with Surveillance, Epidemiology, and End Results (SEER) data validation. Annals of Translational Medicine. 2020;8(17):1075.
26.
DengJLiuJWangW, et al.Validation of clinical significance of examined lymph node count for accurate prognostic evaluation of gastric cancer for the eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging system. Chinese Journal of Cancer Research = Chung-kuo yen cheng yen chiu. 2018;30(5):477-491.
27.
YamashitaHDengJLiangHSetoY. Re-evaluating the prognostic validity of the negative to positive lymph node ratio in node-positive gastric cancer patients. Surgery. 2017;161(6):1588-1596.
28.
Abd-ElhayFAElhusseinyKMKamelMG, et al.Negative Lymph Node Count and Lymph Node Ratio Are Associated With Survival in Male Breast Cancer. Clinical breast cancer. 2018;18(6):e1293-e1310.
29.
HannaGBAmygdalosINiM, et al.Improving the standard of lymph node retrieval after gastric cancer surgery. Histopathology. 2013;63(3):316-324.
30.
QinQLiXLiangX, et al.CDK4/6 inhibitor palbociclib overcomes acquired resistance to third-generation EGFR inhibitor osimertinib in non-small cell lung cancer (NSCLC). Thoracic cancer. 2020;11(9):2389-2397.
31.
MorganJWJiLFriedmanG, et al.The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery. JAMA surgery. 2015;150(1):37-43.
